New: arexvy

zafrada (78)in health • 5 months ago
GSK’s RSV vaccine Arexvy got FDA approval for at-risk adults aged 50-59.
The CDC's ACIP is meeting at the end of the month to discuss it. This comes following their trial data in this age group which saw a benefit. Pfizer for its part is also looking to expand its…
Downvoting a post can decrease pending rewards and make it less visible. Common reasons:
Disagreement on rewards
Fraud or plagiarism
Hate speech or trolling
Miscategorized content or spam

Submit
$11.12
Past Payouts $11.12
- Author $5.57
- Curators $5.55
0

GSK’s RSV vaccine Arexvy got FDA approval for at-risk adults aged 50-59.